Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.59 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | IP6K1 | Q92551 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31337867 | 1.00 | MAOB (0.59) | MAOBBCHEACHEIP6K1TSHR | |
| SCHEMBL4429852 | 0.77 | MAOB (0.42) | MAOBBCHEACHETSHR | |
| SCHEMBL31231150 | 0.74 | MAOB (1.00) | MAOBBCHEACHEIP6K1TSHR | |
| SCHEMBL30311 | 0.74 | MAOB (1.00) | MAOBBCHEACHEIP6K1TSHR | |
| SCHEMBL8530667 | 0.72 | MAOB (0.96) | MAOBBCHEACHEIP6K1TSHR | |
| Bromide SCHEMBL1821620 | 0.72 | MAOB (0.96) | MAOBBCHEACHEIP6K1TSHR | |
| SCHEMBL19042548 | 0.72 | MAOB (0.57) | MAOBBCHEACHEIP6K1TSHR | |
| SCHEMBL1826027 | 0.71 | ACHE (0.72) | MAOBBCHEACHEIP6K1 | |
| SCHEMBL19042688 | 0.69 | MAOB (0.53) | MAOBBCHEACHEIP6K1TSHR | |
| SCHEMBL14493815 | 0.69 | MAOB (0.58) | MAOBBCHEACHEIP6K1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12247300-B2 | Cleaning solution and cleaning method | FUJIFILM CORPORATION (JP) | 2025-03-11 | — | — | US | disclosed |
| US-12012467-B2 | Small molecule DCN1 inhibitors and therapeutic methods using the same | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-06-18 | — | — | US | disclosed |
| CN-115583970-A | Method for preparing alpha- (hydroxy amino) diaryl phosphine oxide from nitrone | 华北理工大学 | 2023-01-10 | — | — | CN | disclosed |
| US-20220275519-A1 | CLEANING SOLUTION AND CLEANING METHOD | FUJIFILM CORPORATION (JP) | 2022-09-01 | — | — | US | disclosed |
| US-20200109167-A1 | SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME | UNIV MICHIGAN REGENTS (US) | 2020-04-09 | — | — | US | disclosed |
| EP-3601245-A1 | SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME | The Regents of The University of Michigan (US) | 2020-02-05 | — | — | EP | disclosed |
| WO-2018183411-A1 | SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2018-10-04 | — | — | WO | disclosed |
| EP-1655070-B1 | OXIDATION CATALYST | ASAHI KASEI CHEMICALS CORP (JP) | 2015-07-15 | — | — | EP | disclosed |
| US-8133834-B2 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2012-03-13 | — | — | US | disclosed |
| CN-1835800-B | Oxidation catalyst | ASAHI CHEMICAL CORP (JP) | 2010-04-28 | — | — | CN | disclosed |
| US-20100069670-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20060229471-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2006-10-12 | — | — | US | disclosed |
| CN-1835800-A | Oxidation catalyst | ASAHI CHEMICAL CORP (JP) | 2006-09-20 | — | — | CN | disclosed |
| EP-1655070-A1 | OXIDATION CATALYST | Asahi Kasei Chemicals Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
| EP-0621276-A1 | Angiotensin II receptor blocking 2,3,6-substituted quinazolinones | AMERICAN CYANAMID COMPANY (US) | 1994-10-26 | — | — | EP | disclosed |
| US-5358951-A | Treating hypertension, congestive heart failure | AMERICAN CYANAMID COMPANY (US) | 1994-10-25 | — | — | US | disclosed |
| US-5292734-A | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones | AMERICAN CYANAMID COMPANY (US) | 1994-03-08 | — | — | US | disclosed |
| US-4596874-A | One step reaction of secondary amine with hydrogen peroxide in the presence of tungsten, molybdenum, vanadium, titamium catalyst | THE PRESIDENT OF OSAKA UNIVERSITY (JP) | 1986-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200109167-A1 | SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME | DCUN1D2, CLN6, CAPNS1 | MAOB 1366/4885BCHE 1455/4885ACHE 1736/4885 |
| US-20100069670-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | MAOB 267/4885BCHE 1176/4885ACHE 1338/4885 |
| US-12012467-B2 | Small molecule DCN1 inhibitors and therapeutic methods using the same | DCUN1D2, CLN6, CAPNS1 | MAOB 1366/4885BCHE 1455/4885ACHE 1736/4885 |
| US-20060229471-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | MAOB 267/4885BCHE 1176/4885ACHE 1338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.